Middletown, DE -- (SBWIRE) -- 09/18/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Rockwell Medical Inc (NASDAQ:RMTI), Activision Blizzard, Inc.(NASDAQ:ATVI), NVIDIA Corporation(NASDAQ:NVDA), Keryx Biopharmaceuticals(NASDAQ:KERX)
Rockwell Medical Inc(NASDAQ:RMTI) opened the session at $9.99, remained amid the day range of $9.51 - $10.49, and closed the session at $9.77. The stock showed a negative performance of -2.30% in previous trading session. The stock gained a volume of 4.31 million shares and the average volume of the stock remained 2.47 million shares. Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD).
Will RMTI Get Buyers Even After The Recent Rally? Find Out Here
Activision Blizzard, Inc.(NASDAQ:ATVI) traded with volume of 4.23 million shares in the prior session and the average volume of the stock remained 5.92 million shares. The 52 week range of the stock remained $10.45 - $18.43. The stock showed a negative movement of -0.52% and closed its session at $17.16. The market capitalization of the stock remained 19.21 billion. Activision Blizzard, Inc. publishes online, personal computer (PC), console, handheld, and mobile interactive entertainment products worldwide. It operates in three segments: Activision, Blizzard, and Distribution. The Activision segment develops and publishes interactive software products and content.
Why Should Investors Buy ATVI After the Recent Fall? Just Go Here and Find Out
NVIDIA Corporation (NASDAQ:NVDA) exchanged 4.22 million shares and the average volume remained 8.26 million shares. The stock escalated +0.32% and closed the session at $15.86. The beta of the stock remained 1.37 and the EPS of the stock remained 0.90. The shares outstanding of the stock remained 578.60 million. NVIDIA Corporation, a visual computing company, develops graphics chips for use in personal computers (PC), mobile devices, and supercomputers. The company operates through two segments, GPU and Tegra Processors. The GPU segment offers GeForce for consumer desktop and notebook PCs; Quadro for professional workstations.
For How Long NVDA will fight for Profitability? Read This Trend Analysis report
Keryx Biopharmaceuticals (NASDAQ:KERX) gained volume of 4.16 million shares, while the average volume remained 1.35 million shares. The stock advanced +7.64% and finished the session Tuesday at $10.00. The EPS of the stock remained -0.33. The one month of the stock was +19.33% and three month trend remained positive +32.28%. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
For How Long KERX’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)